Frankfurt - Delayed Quote EUR
Incyte Corporation (ICY.F)
50.88
+0.12
+(0.24%)
As of 8:04:42 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
335,337
335,337
496,487
969,941
749,488
Investing Cash Flow
157,517
157,517
-207,677
-78,542
-207,699
Financing Cash Flow
-2,021,547
-2,021,547
-20,033
-794
6,176
End Cash Position
1,689,451
1,689,451
3,215,221
2,953,120
2,059,160
Income Tax Paid Supplemental Data
373,056
373,056
378,206
136,242
67,731
Interest Paid Supplemental Data
--
--
--
--
396
Capital Expenditure
-100,163
-100,163
-47,486
-77,833
-181,006
Repayment of Debt
-3,798
-3,798
-3,360
-2,862
-2,417
Repurchase of Capital Stock
-2,004,790
-2,004,790
--
--
--
Free Cash Flow
235,174
235,174
449,001
892,108
568,482
12/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1VRTX.MI Vertex Pharmaceuticals Incorporated
438.15
+1.62%
SABS SAB Biotherapeutics, Inc.
1.3700
+3.79%
PRLD Prelude Therapeutics Incorporated
0.8832
-5.91%
CTXR Citius Pharmaceuticals, Inc.
0.8420
+2.67%
CCCC C4 Therapeutics, Inc.
1.6100
+3.21%
VRTX Vertex Pharmaceuticals Incorporated
492.42
+0.40%
PSTV Plus Therapeutics, Inc.
0.9835
+24.97%
VERV Verve Therapeutics, Inc.
5.47
+4.19%
IOVA Iovance Biotherapeutics, Inc.
3.1900
-0.62%
CRSP CRISPR Therapeutics AG
38.54
-1.76%